Only a few recent articles have investigated biomarker-cognition associations in BD mood phases. Our findings underline that there appear to be central regions involved in BD that are observed in all mood states. However, there appear to be underlying mechanisms of cognitive dysfunction that may vary across different mood states in BD. This review highlights the importance of standardizing the data and the assessment of cognition, as well as the need for biomarkers to help prevent acute symptomatic phases of the disease, and the associated functional and cognitive impairment.
Keyphrases
- bipolar disorder
- major depressive disorder
- cognitive impairment
- mild cognitive impairment
- white matter
- sleep quality
- liver failure
- big data
- multiple sclerosis
- high resolution
- machine learning
- depressive symptoms
- drug induced
- deep learning
- artificial intelligence
- aortic dissection
- high speed
- extracorporeal membrane oxygenation